Sarepta Therapeutics Ownership | Who Owns Sarepta Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sarepta Therapeutics Ownership Summary


Sarepta Therapeutics is owned by 91.29% institutional investors, 4.37% insiders, and 4.34% retail investors. Blackrock is the largest institutional shareholder, holding 10.98% of SRPT shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.14% of its assets in Sarepta Therapeutics shares.

SRPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSarepta Therapeutics91.29%4.37%4.34%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock10.32M10.98%$1.63B
Vanguard group9.04M9.61%$1.43B
Capital investors4.32M4.60%$682.69M
State street4.14M4.41%$654.40M
Janus henderson group3.82M4.06%$602.74M
Avoro capital advisors3.00M3.19%$474.00M
Morgan stanley2.62M2.79%$414.49M
Bank of new york mellon2.13M2.27%$336.64M
Wellington management group llp2.06M2.19%$325.72M
T. rowe price investment management1.96M2.08%$309.46M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Casdin capital1.07M12.95%$169.61M
Ally bridge group (ny)73.50K6.92%$11.61M
Avoro capital advisors3.00M6.31%$474.00M
Finepoint capital lp132.84K5.96%$20.99M
Boxer capital650.00K5.41%$102.70M
Altium capital management lp81.90K5.28%$12.94M
Palo alto investors lp201.68K3.69%$31.87M
Evolutionary tree capital management20.96K3.41%$3.31M
Ikarian capital1.00K2.75%$15.80M
Ghost tree capital55.00K2.72%$8.69M

Top Buyers

HolderShares% AssetsChange
Blackrock10.32M0.04%4.36M
State street4.14M0.03%2.02M
Morgan stanley2.62M0.03%1.73M
Norges bank924.43K0.02%924.43K
Jane street group869.13K0.03%591.02K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---1.41M
Avoro capital advisors3.00M6.31%-1.34M
Wellington management group llp2.06M0.06%-1.18M
Janus henderson group3.82M0.32%-1.08M
Paradigm biocapital advisors lp---947.57K

New Positions

HolderShares% AssetsChangeValue
Norges bank924.43K0.02%924.43K$146.06M
Farallon capital management133.30K0.10%133.30K$21.06M
Balyasny asset management125.00K0.03%125.00K$19.75M
Corebridge financial120.64K0.10%120.64K$19.06M
Retirement systems of alabama116.67K0.07%116.67K$18.43M

Sold Out

HolderChange
Financial gravity asset management-1.00
Harbor investment advisory-1.00
Financial synergies wealth advisors-3.00
Geneos wealth management-4.00
Financial management professionals-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024498-6.57%87,082,917-1.33%911.04%226-23.65%15718.05%
Jun 30, 202452818.39%88,255,3468.04%931.24%29335.02%1324.76%
Mar 31, 20244461.59%81,685,5570.50%861.12%2177.43%126-11.89%
Dec 31, 2023439-1.79%81,281,399-0.52%871.04%202-1.94%14312.60%
Sep 30, 20234471.13%81,706,1990.21%911.09%206-0.48%127-5.93%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF3.00M3.14%1.63K
Vanguard Total Stock Mkt Idx Inv2.84M2.98%-11.17K
Vanguard Small Cap Index2.27M2.38%4.45K
VA CollegeAmerica Amcap 529A2.10M2.20%902.69K
Capital Group AMCAP Composite2.10M2.20%902.69K
Vanguard Health Care Inv1.66M1.74%390.96K
Capital Group Growth Fnd of Amer Comp1.65M1.73%194.73K
American Funds Growth Fund of Amer A1.65M1.73%194.73K
SPDR® S&P Biotech ETF1.50M1.57%16.57K
Vanguard Institutional Extnd Mkt Idx Tr1.42M1.49%-7.05K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 12, 2024Wigzell Hans Lennart Rudolf-Sell$1.31M
Dec 05, 2024Boor Kathryn Jean-Sell$205.40K
Aug 30, 2024Estepan Ian Michael Chief Financial OfficerSell$822.10K
Aug 16, 2024Chambers Michael Andrew-Buy$2.45M
Aug 16, 2024Chambers Michael Andrew-Buy$1.74M

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q331
2024 Q2-14
2024 Q1-9
2023 Q46-

SRPT Ownership FAQ


Who Owns Sarepta Therapeutics?

Sarepta Therapeutics shareholders are primarily institutional investors at 91.29%, followed by 4.37% insiders and 4.34% retail investors. The average institutional ownership in Sarepta Therapeutics's industry, Biotech Stocks , is 47.04%, which Sarepta Therapeutics exceeds.

Who owns the most shares of Sarepta Therapeutics?

Sarepta Therapeutics’s largest shareholders are Blackrock (10.32M shares, 10.98%), Vanguard group (9.04M shares, 9.61%), and Capital investors (4.32M shares, 4.60%). Together, they hold 25.19% of Sarepta Therapeutics’s total shares outstanding.

Does Blackrock own Sarepta Therapeutics?

Yes, BlackRock owns 10.98% of Sarepta Therapeutics, totaling 10.32M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.63B$. In the last quarter, BlackRock increased its holdings by 4.36M shares, a 73.22% change.

Who is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested?

Casdin capital is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested, with 12.95% of its assets in 1.07M Sarepta Therapeutics shares, valued at 169.61M$.

Who is the top mutual fund holder of Sarepta Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of Sarepta Therapeutics shares, with 3.14% of its total shares outstanding invested in 3M Sarepta Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools